NIKKEI 225
38,676.81 -26.70 (-0.07%) HANG SENG
18,536.05 +59.25 (+0.32%) CRUDE OIL
75.54 -0.01 (-0.01%) GOLD FUTURES
2,390.30 -0.60 (-0.03%) DOW
38,886.17 +78.84 (+0.20%) Bitcoin GBP
55,401.19 -228.74 (-0.41%)
MediPharm Labs Corp. (MLZ.F)
| Previous close | 0.0490 |
| Open | 0.0480 |
| Bid | 0.0454 x 0 |
| Ask | 0.0588 x 0 |
| Day's range | 0.0480 - 0.0480 |
| 52-week range | 0.0303 - 0.0700 |
| Volume | |
| Avg. volume | 1,139 |
| Market cap | 19.984M |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
MediPharm Labs Reports First Quarter Results
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024.
- PR Newswire
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31, 2024, before markets open on Wednesday, May 15, 2024.
- PR Newswire
MediPharm Labs Provides Conference Call Recording Details
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, has released and hosted a conference call regarding its full year and fourth quarter financial results for the period ended December 31, 2023.
